Daniel Vitt - Mar 4, 2024 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Signature
/s/ Daniel Vitt
Stock symbol
IMUX
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 09:51 PM
Previous filing
Feb 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Disposed to Issuer -65K -100% 0 Mar 4, 2024 Common Stock 65K $13.29 Direct F1
transaction IMUX Stock Option Disposed to Issuer -80K -100% 0 Mar 4, 2024 Common Stock 80K $12.30 Direct F1
transaction IMUX Stock Option Disposed to Issuer -115K -100% 0 Mar 4, 2024 Common Stock 115K $15.72 Direct F1
transaction IMUX Stock Option Disposed to Issuer -215K -100% 0 Mar 4, 2024 Common Stock 215K $10.73 Direct F1
transaction IMUX Stock Option Disposed to Issuer -10K -100% 0 Mar 4, 2024 Common Stock 10K $3.40 Direct F1
transaction IMUX Stock Option Award +485K 485K Mar 4, 2024 Common Stock 485K $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the "Eligible Options") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date.